Hentapan, Angelita M.

HRN: 00-54-88  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/23/2026
METRONIDAZOLE 500MG (TAB)
06/23/2026
06/30/2026
PO
500 MG
Q8
AGE Amoeboases, DFS WS
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  BloodstreamIntra-abdominal    Compliance to guidelines: Compliant To Guidelines